Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase III Trial, to Evaluate the Efficacy and Safety of a Single Intra-articular Injection of RTX-GRT7039 in Adult Subjects With Pain Associated With Osteoarthritis of the Knee
NCT05449132 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Phase III Trial, to Evaluate the Efficacy and Safety of a Single Intra-articular Injection of RTX-GRT7039 in Adult Subjects With Pain Associated With Osteoarthritis of the Knee
- Lead sponsor
- Grünenthal GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 26, 2022
- Completion date
- August 15, 2024
- Enrollment
- 466 (actual)
- Sites
- 81
Conditions
As the registry lists them; a condition with its own page is linked.